Literature DB >> 7728126

Biology of acute and chronic graft-versus-host reactions: predictive value of studies in experimental animals.

D W van Bekkum1.   

Abstract

Experimental research on graft-versus-host disease (GVHD) with laboratory animals has been performed mainly with rodents, rhesus monkeys and dogs. The basic immunological mechanisms operative in GVHD are largely similar in these three species and in human patients, although the patterns of GVHD in the three animal species show differences. The predictive value for clinical GVHD of the results obtained in the different animals species is analysed for the three main variables: namely, histocompatibility, T cell numbers in the graft and the intestinal microflora. Rhesus monkeys score highest as regards clinical relevance for the first two variables. With regards to the unravelling of detailed mechanisms of the influence of the microflora, none of the three animal species is likely to provide the information needed for identification of the bacterial species involved in the induction of GVHD in human patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7728126

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Cord colitis syndrome: a cause of granulomatous inflammation in the upper and lower gastrointestinal tract.

Authors:  Nitin K Gupta; Ricard Masia
Journal:  Am J Surg Pathol       Date:  2013-07       Impact factor: 6.394

2.  Chitinase 3-Like-1-Deficient Splenocytes Deteriorated the Pathogenesis of Acute Graft-Versus-Host Disease via Regulating Differentiation of Tfh Cells.

Authors:  Zengyao Li; Hao Lu; Jian Gu; Jing Liu; Qin Zhu; Yunjie Lu; Xuehao Wang
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

3.  Obese donor mice splenocytes aggravated the pathogenesis of acute graft-versus-host disease via regulating differentiation of Tregs and CD4+ T cell induced-type I inflammation.

Authors:  Zengyao Li; Jian Gu; Qin Zhu; Jing Liu; Hao Lu; Yunjie Lu; Xuehao Wang
Journal:  Oncotarget       Date:  2017-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.